Fusen Pharmaceutical Company Limited

SEHK:1652 Stock Report

Market Cap: HK$731.9m

Fusen Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:1652 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Apr 24BuyHK$907,546Changcheng CaoIndividual1,041,000HK$0.87
19 Apr 24BuyHK$575,251Changcheng CaoIndividual650,000HK$0.89
18 Apr 24BuyHK$211,993Zhiming CaoIndividual240,000HK$0.88
17 Apr 24BuyHK$223,713Zhiming CaoIndividual265,000HK$0.84

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1652?
Owner TypeNumber of SharesOwnership Percentage
Institutions211,0000.0285%
General Public155,842,00021.1%
Private Companies185,180,00025%
Individual Insiders398,068,00053.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 6 shareholders own 78.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.9%
Changcheng Cao
206,457,000HK$204.4m0%no data
24.4%
Fusen Trust
180,180,000HK$178.4m0%no data
20.9%
Zhiming Cao
154,651,000HK$153.1m0%no data
5%
Yiupor Lam
36,960,000HK$36.6m0%no data
0.68%
The Core Trust Company Limited
5,000,000HK$4.9m0%no data
0.029%
Dimensional Fund Advisors LP
211,000HK$208.9k-0.94%no data